treosulfan has been researched along with Leukocytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belau, A; Fuxius, S; Heidrich-Lorsbach, E; Heuser, T; Klare, P; Kölbl, H; Mahner, S; Markmann, S; Oskay-Özcelik, G; Ruhmland, B; Sehouli, J; Sommer, H | 1 |
| Baumgart, J; Bechrakis, NE; Bornfeld, N; Foerster, MH; Keilholz, U; Scheulen, ME; Schmittel, A; Strumberg, D; Thiel, E | 1 |
2 trial(s) available for treosulfan and Leukocytopenia
| Article | Year |
|---|---|
A prospective multicenter study of treosulfan in elderly patients with recurrent ovarian cancer: results of a planned safety analysis.
Topics: Aged; Aged, 80 and over; Alopecia; Anemia; Antineoplastic Agents, Alkylating; Busulfan; Constipation; Drug Administration Schedule; Fatigue; Female; Humans; Leukopenia; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Prospective Studies; Quality of Life; Recurrence; Surveys and Questionnaires; Treatment Outcome | 2012 |
Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma.
Topics: Adult; Aged; Anemia; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cisplatin; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Leukopenia; Male; Melanoma; Middle Aged; Survival Analysis; Thrombocytopenia; Uveal Neoplasms | 2005 |